Tag Archives: antipsychotic

Former Top Industry Insider Reveals Big Pharma Secrets

Posted on September 28, 2014 by cchrstl

Former Top Industry Insider Reveals Big Pharma Secrets [From American Free Press Newspaper] “The former managing director of drug giant Eli Lilly and Company in Sweden continues to blow the whistle on the business practices of the pharmaceutical industry, scoring … Continue reading →

Posted in Big Muddy River Newsletter, Press Releases | Tagged , , , , , , | Leave a comment

The Deadliest Enemy

Posted on September 7, 2014 by cchrstl

The Deadliest Enemy is the one you never suspect “The use of psychotropic drugs, especially combined use of antipsychotic and antidepressant drugs, is strongly associated with an increased risk of SCD [Sudden Cardiac Death].” —European Heart Journal “Prior to the … Continue reading →

Posted in Big Muddy River Newsletter, Press Releases | Tagged , , , , , , | Leave a comment

Psychiatric drug ER trips approach 90,000 a year

Posted on July 19, 2014 by cchrstl

Psychiatric drug ER trips approach 90,000 a year “Bad reactions to psychiatric drugs result in nearly 90,000 emergency room visits each year by U.S. adults, with anti-anxiety medicines and sedatives among the most common culprits. “A drug used in some … Continue reading →

Posted in Big Muddy River Newsletter, Press Releases | Tagged , , , , , | Leave a comment

Johnson & Johnson Will Pay $2.2 Billion

Posted on November 27, 2013 by cchrstl

Johnson & Johnson Will Pay $2.2 Billion to Settle Charges of Illegally Promoting Antipsychotic Drug This past month Johnson & Johnson agreed to pay more than $2.2 billion in fines to settle accusations that it improperly promoted the antipsychotic drug … Continue reading →

Posted in Big Muddy River Newsletter, Press Releases | Tagged , , , , | Leave a comment

Fake Article in Psych Research Journal

Posted on November 11, 2013 by cchrstl

Fake Article in Psych Research Journal A Norwegian study that claims to have observed significant brain changes in mental patients who switched from so-called “first generation” antipsychotic drugs to second generation varieties has been retracted from the peer-reviewed journal BMC … Continue reading →

Posted in Big Muddy River Newsletter, Press Releases | Tagged , , | Leave a comment

U.S. Probes Psych Drugs on Kids

Posted on September 8, 2013 by cchrstl

U.S. Probes Psych Drugs on Kids The Wall Street Journal (WSJ) carried this report August 11, “U.S. Probes Use of Antipsychotic Drugs on Children,” sub-titled “Federal health officials are reviewing antipsychotic drug use on children in the Medicaid system.” Concerned … Continue reading →

Posted in Big Muddy River Newsletter, Press Releases | Tagged , , , , | 1 Comment

Nursing Home Abuses

Posted on July 25, 2013 by cchrstl

Nursing Home Abuses The June 2013 issue of Consumer Reports magazine had this to say about antipsychotic drugs given to nursing home patients: “These and related drugs are supposed to be used only for patients with diagnosed psychiatric conditions such … Continue reading →

Posted in Big Muddy River Newsletter, Press Releases | Tagged , , , , , , , , | 4 Comments

Military’s Use of Powerful Psychiatric Drugs

Posted on July 11, 2013 by cchrstl

FOX Special Report Series Military’s Use of Powerful Psychiatric Drugs Last month FOX National News released a three-part series on the drugging of our nation’s military, produced by award-winning investigative reporter Douglas Kennedy, and assisted by CCHR International. The first … Continue reading →

Posted in Big Muddy River Newsletter, Press Releases | Tagged , , , , , | Leave a comment

Prenatal Antipsychotic Exposure

Posted on June 17, 2012 by cchrstl

“Prenatal Antipsychotic Exposure” refers to the harm done to a child in the womb when a pregnant mother takes antipsychotic drugs. Apparently this is a relatively common occurrence. There has been a 170% increase over the last decade in antipsychotic use … Continue reading →

Posted in Big Muddy River Newsletter, Press Releases | Tagged , | 1 Comment

J&J reportedly agrees to $1 billion settlement on Risperdal

Posted on January 12, 2012 by cchrstl

J&J reportedly agrees to $1 billion settlement on Risperdal “Johnson & Johnson will pay more than $1 billion to the U.S. and most states to resolve a civil investigation into marketing of the antipsychotic Risperdal, according to people familiar with … Continue reading →

Posted in Big Muddy River Newsletter, Press Releases | Tagged , , , | 1 Comment